About Rezolute (RZLT)
Rezolute, Inc. is a clinical-stage biopharmaceutical company, which is developing therapies for metabolic diseases related to chronic glucose imbalance. The Company’s lead clinical asset, RZ358, is in late-stage development for the treatment of conge... Read more
- USD3.74
- USD3.85
- USD3.58
- USD6.19
- 28.30%
- --
- 337.79k
- 1.77M
- 313M
- 2.22
- 41.40%
Stock News
3 hours ago
Royal Caribbean boosts profit outlook as record bookings highlight cruise appeal
MarketWatch
3 hours ago
Honeywell shares jump on strong earnings. Here is Jim Cramer's advice on the stock
CNBC
4 hours ago
United Airlines grows highest-end Polaris airport lounge by 50% in battle for wealthy customers
CNBC
4 hours ago
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
